Sanofi - Common Stock and American Depositary Receipts (SNY)

Historical Holders from Q1 2014 to Q3 2025

Symbol
SNY on Nasdaq
Type / Class
Equity / Common Stock and American Depositary Receipts
Shares outstanding
1.23B
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
238M
Holdings value
$11.2B
% of all portfolios
0.013%
Grand Portfolio weight change
-0.001%
Number of holders
692
Number of buys
312
Number of sells
-339
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sanofi - Common Stock and American Depositary Receipts (SNY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Amundi 5.21% +3.6% $3.02B $100M 63.9M +3.45% AMUNDI 30 Sep 2025

Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 238M $11.2B -$540M $47.20 692
2025 Q2 245M $11.8B -$578M $48.31 717
2025 Q1 260M $14.4B -$180M $55.46 757
2024 Q4 264M $12.8B -$860M $48.23 720
2024 Q3 281M $16.2B +$600M $57.63 744
2024 Q2 271M $13.2B +$735M $48.52 712
2024 Q1 257M $12.5B +$459M $48.60 698
2023 Q4 247M $12.3B -$269M $49.73 698
2023 Q3 252M $13.5B -$169M $53.64 687
2023 Q2 254M $13.7B -$663M $53.90 664
2023 Q1 264M $14.4B +$296M $54.42 662
2022 Q4 261M $12.7B +$345M $48.43 630
2022 Q3 254M $9.68B -$221M $38.02 562
2022 Q2 258M $12.9B +$532M $50.03 637
2022 Q1 252M $12.9B +$356M $51.34 610
2021 Q4 244M $12.2B +$342M $50.10 612
2021 Q3 236M $11.4B +$1.64B $48.21 572
2021 Q2 202M $10.6B +$298M $52.66 579
2021 Q1 197M $9.73B +$1.14B $49.46 565
2020 Q4 175M $8.49B +$61.8M $48.59 595
2020 Q3 173M $8.68B -$298M $50.17 566
2020 Q2 179M $9.14B -$395M $51.05 575
2020 Q1 187M $8.17B +$343M $43.72 539
2019 Q4 179M $9.01B +$33.5M $50.20 522
2019 Q3 179M $8.28B +$158M $46.33 478
2019 Q2 175M $7.58B -$253M $43.27 475
2019 Q1 181M $8.03B +$105M $44.28 486
2018 Q4 179M $7.77B +$83M $43.41 498
2018 Q3 177M $7.89B -$512M $44.67 475
2018 Q2 189M $7.56B -$944M $40.01 471
2018 Q1 213M $8.52B -$561M $40.08 481
2017 Q4 226M $9.71B -$178M $43.00 499
2017 Q3 229M $11.4B -$297M $49.79 481
2017 Q2 235M $11.3B -$672M $47.91 472
2017 Q1 250M $11.3B +$51.2M $45.25 454
2016 Q4 250M $10.1B -$99.3M $40.44 474
2016 Q3 253M $9.65B +$379M $38.19 444
2016 Q2 242M $10.1B +$486M $41.85 443
2016 Q1 231M $9.32B +$92.6M $40.16 441
2015 Q4 228M $9.73B -$541M $42.65 474
2015 Q3 241M $11.4B -$462M $47.47 489
2015 Q2 253M $12.5B -$260M $49.53 494
2015 Q1 257M $12.7B +$435M $49.44 509
2014 Q4 250M $11.4B +$343M $45.61 492
2014 Q3 241M $13.6B +$166M $56.43 497
2014 Q2 238M $12.7B +$119M $53.17 484
2014 Q1 236M $12.3B +$580M $52.28 485